Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Brody

Showing results (31-40 of 170) with videos related to

Pageof 17
Sort By:
Cancer Treatment and Research|November 17, 2023
Strategies for the Management of Patients with Pancreatic Cancer with PARP InhibitorsTalia Golan, Maria Raitses-Gurevich, Tamar Beller, et al.
Cancer Research|September 8, 2023
Targeting the RNA-Binding Protein HuR in CancerJennifer M Finan, Thomas L Sutton, Dan A Dixon, et al.
Frontiers in Oncology|January 7, 2014
Structural Implications for Selective Targeting of PARPsJamin D Steffen, Jonathan R Brody, Roger S Armen, et al.
Wiley Interdisciplinary Reviews. RNA|January 24, 2020
Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)Christopher W Schultz, Ranjan Preet, Teena Dhir, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2018
Evaluation of Post-transcriptional Gene Regulation in Pancreatic Cancer Cells: Studying RNA Binding Proteins and Their mRNA TargetsAditi Jain, Samantha Z Brown, Henry L Thomsett, et al.
International Journal of Biological Sciences|March 2, 2016
The Landscape of Pancreatic Cancer Therapeutic Resistance MechanismsSaswati Chand, Kevin O'Hayer, Fernando F Blanco, et al.
Biotechniques|November 3, 2004
Ultra-fast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive mediaJonathan R Brody, Eric S Calhoun, Eike Gallmeier, et al.
Future Oncology (London, England)|November 12, 2009
The 'RNA-binding ome': future implications for chemotherapeutic efficacyJonathan R Brody, Agnieszka K Witkiewicz, Charles J Yeo, et al.
Cancer Research|July 3, 2008
A syngeneic variance library for functional annotation of human variation: application to BRCA2Tomas Hucl, Carlo Rago, Eike Gallmeier, et al.
Molecular Cancer Therapeutics|November 3, 2019
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic ImplicationsSamantha A Armstrong, Christopher W Schultz, Ariana Azimi-Sadjadi, et al.
Pageof 17

Showing results (31-40 of 170) with videos related to

Sort By:
Pageof 17
Cancer Treatment and Research|November 17, 2023
Strategies for the Management of Patients with Pancreatic Cancer with PARP InhibitorsTalia Golan, Maria Raitses-Gurevich, Tamar Beller, et al.
Cancer Research|September 8, 2023
Targeting the RNA-Binding Protein HuR in CancerJennifer M Finan, Thomas L Sutton, Dan A Dixon, et al.
Frontiers in Oncology|January 7, 2014
Structural Implications for Selective Targeting of PARPsJamin D Steffen, Jonathan R Brody, Roger S Armen, et al.
Wiley Interdisciplinary Reviews. RNA|January 24, 2020
Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)Christopher W Schultz, Ranjan Preet, Teena Dhir, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2018
Evaluation of Post-transcriptional Gene Regulation in Pancreatic Cancer Cells: Studying RNA Binding Proteins and Their mRNA TargetsAditi Jain, Samantha Z Brown, Henry L Thomsett, et al.
International Journal of Biological Sciences|March 2, 2016
The Landscape of Pancreatic Cancer Therapeutic Resistance MechanismsSaswati Chand, Kevin O'Hayer, Fernando F Blanco, et al.
Biotechniques|November 3, 2004
Ultra-fast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive mediaJonathan R Brody, Eric S Calhoun, Eike Gallmeier, et al.
Future Oncology (London, England)|November 12, 2009
The 'RNA-binding ome': future implications for chemotherapeutic efficacyJonathan R Brody, Agnieszka K Witkiewicz, Charles J Yeo, et al.
Cancer Research|July 3, 2008
A syngeneic variance library for functional annotation of human variation: application to BRCA2Tomas Hucl, Carlo Rago, Eike Gallmeier, et al.
Molecular Cancer Therapeutics|November 3, 2019
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic ImplicationsSamantha A Armstrong, Christopher W Schultz, Ariana Azimi-Sadjadi, et al.
Pageof 17